نتایج جستجو برای: egfr

تعداد نتایج: 30143  

2012
Tariq Shafi Kunihiro Matsushita Elizabeth Selvin Yingying Sang Brad C Astor Lesley A Inker Josef Coresh

BACKGROUND The Chronic Kidney Disease Epidemiology Collaboration equation for estimation of glomerular filtration rate (eGFR(CKD-EPI)) improves GFR estimation compared with the Modification of Diet in Renal Disease Study equation (eGFR(MDRD)) but its association with mortality in a nationally representative population sample in the US has not been studied. METHODS We examined the association ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Urszula Dougherty Reba Mustafi Farhana Sadiq Anas Almoghrabi Devkumar Mustafi Maggi Kreisheh Sumana Sundaramurthy Weicheng Liu Vani J Konda Joel Pekow Sharad Khare John Hart Loren Joseph Alice Wyrwicz Gregory S Karczmar Yan Chun Li Marc Bissonnette

PURPOSE We previously showed that EGF receptor (EGFR) promotes tumorigenesis in the azoxymethane/dextran sulfate sodium (AOM/DSS) model, whereas vitamin D suppresses tumorigenesis. EGFR-vitamin D receptor (VDR) interactions, however, are incompletely understood. Vitamin D inhibits the renin-angiotensin system (RAS), whereas RAS can activate EGFR. We aimed to elucidate EGFR-VDR cross-talk in col...

Journal: :Cancer research 2008
Kelly L Mueller Lauren A Hunter Stephen P Ethier Julie L Boerner

Breast cancers are not responsive to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), although 30% of breast cancers overexpress EGFR. The mechanism of intrinsic resistance to EGFR TKIs in breast cancer is the focus of current studies. Here, we observed that EGFR remains tyrosine phosphorylated in breast cancer cells that proliferate in the presence of EGFR TKIs. In one...

2012
Aislyn D. W. Boran Joseph Seco Vinodh Jayaraman Gomathi Jayaraman Shan Zhao Sushmitha Reddy Yibang Chen Ravi Iyengar

The epidermal growth factor receptor (EGFR) is involved in many cancers and EGFR has been heavily pursued as a drug target. Drugs targeting EGFR have shown promising clinical results for several cancer types. However, resistance to EGFR inhibitors often occurs, such as with KRAS mutant cancers, therefore new methods of targeting EGFR are needed. The juxtamembrane (JXM) domain of EGFR is critica...

2013
Gijs Van Pottelbergh Wendy PJ Den Elzen Jan Degryse Jacobijn Gussekloo

BACKGROUND The prevalence of chronic kidney disease is high in the elderly, but the effects of a decrease in the eGFR on mortality and functioning are still unclear. The aim of this study was to determine whether the combination of the eGFR and the eGFR slope is a predictor of mortality and functional decline. METHODS The eGFR (MDRD equation) and the eGFR slope were calculated. The slope was ...

Journal: :PLoS pathogens 2016
Michael G Currier Sujin Lee Christopher C Stobart Anne L Hotard Remi Villenave Jia Meng Carla D Pretto Michael D Shields Minh Trang Nguyen Sean O Todd Michael H Chi Jason Hammonds Stefanie A Krumm Paul Spearman Richard K Plemper Kaori Sakamoto R Stokes Peebles Ultan F Power Martin L Moore

Respiratory syncytial virus (RSV) is the major cause of viral lower respiratory tract illness in children. In contrast to the RSV prototypic strain A2, clinical isolate RSV 2-20 induces airway mucin expression in mice, a clinically relevant phenotype dependent on the fusion (F) protein of the RSV strain. Epidermal growth factor receptor (EGFR) plays a role in airway mucin expression in other sy...

2017
Guowei Zhang Ruirui Cheng Zengli Zhang Tao Jiang Shengxiang Ren Zhiyong Ma Sha Zhao Caicun Zhou Jun Zhang

Whether bisphosphonates could enhance the effect of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in non-small-cell lung cancer (NSCLC) patients with EGFR mutation and bone metastases (BM) remains unknown. EGFR mutation status were collected from 1560 patients with NSCLC and BM. 356 NSCLC patients with EGFR mutation and BM were identified. Among them, 91 patients rec...

Journal: :Lung cancer 2013
A Jasmijn Hubers Daniëlle A M Heideman Yasushi Yatabe Michelle D Wood Justyna Tull Miquel Tarón Miquel A Molina Clara Mayo Jordi Bertran-Alamillo Gerarda J M Herder Remco Koning Daoud Sie Bauke Ylstra Gerrit A Meijer Peter J F Snijders Birgit I Witte Pieter E Postmus Egbert F Smit Erik Thunnissen

OBJECTIVES Epidermal growth factor receptor (EGFR) mutations have been identified in lung adenocarcinomas and are associated with high response chance to EGFR tyrosine kinase inhibitors. EGFR mutations can be detected in tumour tissue, cytology specimens and blood from lung cancer patients. Thus far, EGFR mutation analysis has not been systematically demonstrated for sputum samples. The aim of ...

2012
Sarah Wheeler Doris R. Siwak Raymond Chai Courtney LaValle Raja R. Seethala Lin Wang Kathleen Cieply Carol Sherer Corwin Joy Gordon B. Mills Athanassios Argiris Jill M. Siegfried Jennifer R. Grandis Ann Marie Egloff

Purpose: To assess the prognostic value of epidermal growth factor receptor (EGFR) molecular characteristics of head and neck squamous cell carcinoma (HNSCC). Patients andMethods:HNSCC tumors frompatients prospectively enrolled in either an EarlyDetection Research Network (EDRN) study and treated with surgery without an EGFR-targeted agent (N 1⁄4 154) or enrolled in a chemoradiation trial invol...

2016
Yasemin Saygideğer-Kont Tsion Zewdu Minas Hayden Jones Sarah Hour Haydar Çelik Idil Temel Jenny Han Nese Atabey Hayriye Verda Erkizan Jeffrey A. Toretsky Aykut Üren

Ezrin is a scaffolding protein that is involved in oncogenesis by linking cytoskeletal and membrane proteins. Ezrin interacts with epidermal growth factor receptor (EGFR) in the cell membrane, but little is known about the effects of this interaction on EGFR signaling pathway. In this study, we established the biological and functional significance of ezrin-EGFR interaction in non-small cell lu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید